Genomic Services
Total Trials
7
As Lead Sponsor
6
As Collaborator
1
Total Enrollment
352
NCT00028405
Photodynamic Therapy System for Patients With Refractory/Unresponsive Solid Tumors
Phase: Phase 1
Role: Lead Sponsor
Start: Nov 30, 2001
Completion: Dec 31, 2002
NCT00068068
Photodynamic Therapy With Talaporfin Sodium (LS11) in Treating Patients With Refractory Colorectal Liver Metastases
Phase: Phase 2
Start: Oct 31, 2003
Completion: Not specified
NCT00083785
Study of the Litx™ System Combined With Chemotherapy in Patients With Colorectal Liver Metastases
Start: May 31, 2004
NCT00102115
Study of Talaporfin Sodium Photodynamic Therapy to Treat Advanced Age Related Macular Disease
Start: Dec 31, 2004
Completion: Jan 31, 2006
NCT00375544
Study to Evaluate the Safety and Efficacy of a Low Level Light Device in Patients With Knee Osteoarthritis
Start: Sep 30, 2006
Completion: Nov 30, 2007
NCT01542528
Integrated Brain, Body and Social Intervention for Attention Deficit Hyperactivity Disorder (ADHD)
Phase: N/A
Role: Collaborator
Start: Mar 31, 2012
Completion: Jul 31, 2016
NCT04587245
The Provider Insurance Revenue Study in Healthcare Providers in the United States of America
Start: Oct 1, 2020
Completion: Oct 15, 2022
Loading map...